Navigation Links
Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment
Date:9/17/2011

ster, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (Media)
Arvind Sood, 805-447-1060 (Investors)

(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

(1)  "Facts and statistics about osteoporosis and its impact." International
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
2. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
3. XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
4. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
5. Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
6. The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
7. XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
8. Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
9. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
10. Vantage Health Announces That All of Its Required Tanzanian Registrations, Permits and Licenses Have Been Formally Issued, Simultaneous With Official Notification That Its Application for Phase One Evaluation of Its HIV Screening Test Kits Has Been
11. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, ... Dr. Helen Torley , President and Chief Executive ... will be webcast through the "Investors" section of Halozyme,s corporate ... made available for 90 days following the event. To access ...
(Date:11/24/2014)...  CryoLife, Inc. (NYSE: CRY ), a leading ... vascular surgery, announced today that it will participate in the ... Wednesday, December 3, 2014 at The New York Palace Hotel ... A live webcast of the Company,s presentation is scheduled to ... of the company by Pat Mackin , President and ...
(Date:11/24/2014)... Nov. 24, 2014 /PRNewswire/ - Milestone Pharmaceuticals, Inc. today ... in Melbourne, Australia of ... potential treatment of paroxysmal supraventricular tachycardia (PSVT).  The ... was well tolerated at single doses up to ... profile, desirable PK properties including rapid onset, and ...
Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3
... Calif., Feb. 28, 2011 WaferGen Biosystems, Inc. (OTC ... of state-of-the-art genomic analysis systems, today announced that industry ... Pediatrics at the University of Southern California (USC) Keck ... of WaferGen. "Dr. Triche joined our ...
... ALTO, Calif., Feb. 28, 2011 Varian Medical Systems, Inc. ... entered into a new agreement with Bank of America N.A. ... accelerated share repurchase program.   Under the accelerated ... America N.A. and receive approximately 3.5 million shares, or 85% ...
Cached Medicine Technology:WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors 2WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors 3WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors 4WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors 5Varian Medical Systems Announces New $280 Million Accelerated Stock Repurchase 2Varian Medical Systems Announces New $280 Million Accelerated Stock Repurchase 3
(Date:11/26/2014)... Arlington, VA (PRWEB) November 26, 2014 ... foster greater effectiveness in containing and stopping Ebola, ... long-term stability in healthcare systems in West Africa. ... Care Systems to Stop Ebola: Anthropologists Offer Insights,” ... held by the American Anthropological Association (AAA), Fri., ...
(Date:11/26/2014)... 2014 For those with a New Year’s ... MILLS BODYPUMP™ classes at the University of Colorado Anschutz ... been looking for. The 45- 60 minute classes have just ... Wellness Center fitness club memberships. , LES MILLS BODYPUMP™ exercise ... and are aimed at fast results , By focusing ...
(Date:11/26/2014)... of the most important and vital decisions a woman ... choosing the ideal wedding dress and bridesmaid dresses. BellasDress.com ... quality outfits. Today, BellasDress.com has unveiled its new range ... suitable bridesmaid gowns here at discount prices. , Formal ... and highlight all their most beautiful features while drawing ...
(Date:11/26/2014)... 2014 (HealthDay News) -- The number of emergency department visits ... 2010 to a record 136 million in 2011, according to ... findings also showed that fewer people were going to ERs ... as needing medical care within two hours of arriving at ... to the research. Sixty percent of patients arrived at ...
(Date:11/26/2014)... News) -- Parents need to take an active role ... warns. Parents must make sure sports-playing teens have ... Dodick, chair of the American Migraine Foundation and a ... Medicine in Scottsdale, Ariz. in an American Migraine Foundation, ... coach involved with teens sports needs to have appropriate ...
Breaking Medicine News(10 mins):Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Royal Blue Bridesmaid Dresses Now Are Available for Christmas at BellasDress.com 2Health News:ER Visits on the Rise, Study Reports 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2
... ... An Angel" Launches on iTunes August 25; Percentage of Proceeds to Inspire People to Sign ... , ... 25, 2009 -- All-4-One, the male vocal quartet that scored an international smash with the ...
... , ROCKVILLE, Md., Aug. 25 ... medicines for patients on behalf of both countries, the U.S. ... of the United Mexican States (FEUM) today agreed to collaborate ... a key component of public health, helping to ensure the ...
... , , CENTER CITY, Minn., ... people reclaim their lives from addiction, has appointed William C. ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061128/CGTU038LOGO ) , (Photo: http://www.newscom.com/cgi-bin/prnh/20090825/DC66080 ... announce the appointment of William C. Moyers as Vice President ...
... common among visitors to Indian subcontinent, CDC reports , ... the most common cause of infection with an antimicrobial-resistant ... States, a new study finds. , About 300 cases ... each year, and the majority of these cases are ...
... factors other than gender may be to blame, researchers say ... likely to die than men in the 30 days after ... the trend, a new study finds. , Rather, "the difference ... as age and the presence of other illnesses, said study ...
... too little is known about these ,in situ, malignancies, experts ... of women with breast cancer in situ in the United States ... 2016 that number is expected to increase to more than 1 ... of newly diagnosed breast cancers. It is the early stage of ...
Cached Medicine News:Health News:R&B / Pop Vocal Quartet All-4-One Makes 7-Year Comeback 2Health News:R&B / Pop Vocal Quartet All-4-One Makes 7-Year Comeback 3Health News:Quality of Medicines Advanced by Agreement Between USP, Mexican Standards Body 2Health News:William C. Moyers Appointed Vice President of Foundation Relations for Hazelden 2Health News:International Travel Raises Risk of Typhoid 2Health News:Women More Prone to Die in Month After Heart Attack 2Health News:Women More Prone to Die in Month After Heart Attack 3Health News:More Women Surviving After Early Breast Cancer 2Health News:More Women Surviving After Early Breast Cancer 3
Transcranil vascular DWL doppler....
... The Nicolet VersaLab ... or line-operated Doppler system ... peripheral vasculature. Crisp, clear ... complemented with a display ...
... The Blackstone Spinal Fixation ... fixation system that provides ... spinal stabilization. It combines ... and stability with a ...
... Equation System incorporates a semi-rigid design that ... is a reduced-volume and top-tightening spinal instrumentation ... fixation that mimics the load distribution of ... to share, not bear, the load). Stabilizes ...
Medicine Products: